Latest filing published 31 Jan 2025 for Black Diamond Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Brent Hatzis-Schoch on record concern Black Diamond Therapeutics, Inc. In total, 2 filings cover trades dated from 12 May 2021 to 30 January 2025.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 31 January 2025 with a share grant in Black Diamond Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations